William Guyer

Chief Development Officer, Corcept Therapeutics

Bought, 12 months

$0.0M

Sold, 12 months

$13.1M

Companies

Latest trade

Aug 10, 2026

Companies

Corcept TherapeuticsChief Development Officer −$14.9M

Trades

CORT Sold 16,300 shares at $113.43 · planned $1.8M Aug 10

CORT Sold 3,700 shares at $113.12 · planned $0.4M Aug 4

CORT Sold 20,000 shares at $93.13 · planned $1.9M Jul 7

CORT Sold 20,000 shares at $70.60 · planned $1.4M Jun 2

CORT Sold 20,000 shares at $51.83 · planned $1.0M May 5

CORT Sold 20,000 shares at $40.97 · planned $0.8M Apr 7

CORT Sold 11,767 shares at $36.01 · planned $0.4M Mar 20

CORT Sold 8,233 shares at $35.99 · planned $0.3M Mar 4

CORT Sold 20,000 shares at $40.87 · planned $0.8M Feb 3

CORT Sold 20,000 shares at $35.18 · planned $0.7M Jan 6

CORT Sold 20,000 shares at $80.08 · planned $1.6M Dec 2

CORT Sold 4,500 shares at $80.90 $0.4M Nov 25

CORT Sold 20,000 shares at $75.36 · planned $1.5M Nov 5

CORT Sold 20,000 shares at $89.94 · planned $1.8M Oct 7

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.